Fmoc-L-Tic-OH

Fmoc-L-Tic-OH is an Fmoc-protected amino acid derivative in which the side chain is based on Tic (Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid), providing a conformationally constrained, cyclic tertiary amine-containing scaffold. The molecule bears an Fmoc carbamate protecting group on the α-amino functionality while retaining a free carboxylic acid, and it is specified as the L stereochemical form at the α-carbon. In peptide synthesis workflows, the Fmoc-protected format supports stepwise assembly on solid or solution-phase protocols by controlling chemoselectivity of the α-amino group while the cyclic side chain can be incorporated into peptide analogues for structure-property studies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP23706

CAS No:136030-33-6

Synonyms/Alias:Fmoc-L-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;Fmoc-Tic-OH;136030-33-6;(S)-2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylicacid;Fmoc-L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylicacid;(S)-(+)-2-(9-Fluorenylmethoxycarbonyl)-1,2,3,4-Tetrahydro-3-IsoquinolinecarboxylicAcid;ST081367;(3S)-2-(9H-fluoren-9-ylmethoxycarbonyl)-3,4-dihydro-1H-isoquinoline-3-carboxylicacid;(S)-N-Fmoc-1,2,3,4-tetrahydroisoquinoline-3-carboxylicacid;Fmoc-L-Tic;PubChem6028;AC1LJQO9;47701_ALDRICH;SCHEMBL119605;47701_FLUKA;CTK3J8282;MolPort-001-758-468;ZINC621966;CF-367;MFCD00144368;FL090-1;RTR-004842;VA50663;AJ-23759;AK-46266;AN-31951

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C25H21NO4
M.W/Mr.
399.5

Fmoc-L-Tic-OH is an Fmoc-protected L-amino acid derivative where the stereogenic center corresponds to the L-configuration of the amino acid backbone and the side chain is based on the Tic scaffold (often described as a constrained, sulfur-containing heterocyclic/indole-like amino acid motif). The molecule contains a fluorenylmethoxycarbonyl (Fmoc) carbamate protecting group on the amino functionality, a free carboxylic acid for C-terminal chemistry, and an aromatic/heteroaromatic side chain that can participate in π-stacking and hydrophobic packing during peptide folding. The presence of the Fmoc group enables orthogonal protection behavior under standard peptide synthesis deprotection conditions, while the carboxylic acid supports peptide coupling to form amide bonds. The constrained, chiral side-chain architecture makes Fmoc-L-Tic-OH a stereochemically defined building block for constructing rigid peptidic and peptidomimetic structures used as research intermediates and synthetic targets.

1. Peptide Synthesis

Fmoc-L-Tic-OH is applied in solid-phase peptide synthesis and solution-phase peptide assembly where the Fmoc carbamate enables controlled N-protection and subsequent deprotection to expose the reactive amine for stepwise coupling. The free carboxylic acid and the protected amino group configuration support amide bond formation with common coupling reagents, allowing incorporation of the Tic residue at defined positions in peptide sequences. The constrained, chiral side chain can influence local conformational preferences, which is relevant for generating peptides with altered secondary-structure propensity and binding-site geometry. Downstream, Fmoc-L-Tic-OH-derived peptides serve as scaffold components for library synthesis, structure-activity relationship studies, and method development in peptide chemistry.

2. Peptidomimetics And SAR

Fmoc-L-Tic-OH is used for peptidomimetic construction in medicinal chemistry research where the aromatic, heteroatom-containing Tic side chain provides a rigidified pharmacophore element. The stereodefined L-amino acid backbone and orthogonally protected N-terminus allow systematic substitution patterns to be introduced during analog generation, supporting structure-activity relationship studies that correlate side-chain constraints with molecular recognition. The Fmoc-protected nitrogen and terminal carboxylic acid facilitate conversion into longer amide-linked frameworks or capped derivatives for tuning sterics and polarity. Resulting Tic-containing analogs can be carried forward as research intermediates for fragment elaboration, SAR mapping, and comparative scaffold evaluation within amino acid derivatization workflows.

3. Chemical Biology Probes

Fmoc-L-Tic-OH is suitable for chemical biology and biomolecule labeling strategies where peptide or peptidomimetic constructs can be functionalized downstream while maintaining a defined chiral residue. The Fmoc-protected amine supports incorporation into targeting peptides that later undergo orthogonal deprotection and further derivatization, including conjugation handles introduced at termini or side-chain positions. The heteroaromatic Tic motif can contribute to noncovalent interactions that affect probe binding profiles in assay formats without requiring additional functional groups on the residue itself. L-Tic-containing probe intermediates prepared from Fmoc-L-Tic-OH can be used to generate labeled peptides for binding studies, crosslinking reagent design, and assay reagent synthesis in biochemical research.

4. Protected Amino Acid Chemistry

Fmoc-L-Tic-OH is employed as a chiral protected amino acid derivative for building protected amino acid synthesis routes and intermediate preparation in fine chemical manufacturing. The Fmoc carbamate provides a stable N-protection strategy compatible with standard peptide coupling conditions, while the free carboxylic acid enables conversion into activated esters or direct coupling to form amide linkages as part of synthetic sequences. The stereogenic L-configuration is preserved through the protected amino acid stage, supporting reproducible stereochemical outcomes in downstream peptide assembly. Fmoc-L-Tic-OH can be incorporated into process chemistry intermediate sets for generating Tic-containing fragments used in peptide building block preparation and controlled synthesis of rigid amino acid analogs.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-Tic-OH is relevant to pharmaceutical manufacturing workflows that rely on reproducible peptide or peptidomimetic intermediate generation for research-to-development chemical production. The Fmoc-protected N-terminus and terminal carboxylic acid allow integration into scalable peptide coupling steps, enabling consistent incorporation of the Tic residue into drug-like peptide fragments and related process intermediates. The constrained aromatic side chain can reduce conformational variability in the final sequence, which may support downstream purification behavior and consistent intermediate properties during manufacturing scale-up planning. Fmoc-L-Tic-OH-derived intermediates can therefore serve in industrial fine chemical synthesis for producing defined chiral peptide components and peptidomimetic building blocks used across applied product development pipelines.

Abbr
Fmoc-Tic-OH
InChI
1S/C25H21NO4/c27-24(28)23-13-16-7-1-2-8-17(16)14-26(23)25(29)30-15-22-20-11-5-3-9-18(20)19-10-4-6-12-21(19)22/h1-12,22-23H,13-15H2,(H,27,28)/t23-/m0/s1
InChI Key
LIRBCUNCXDZOOU-QHCPKHFHSA-N
Canonical SMILES
C1C(N(CC2=CC=CC=C21)C(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)C(=O)O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesPeptide CDMOEpitope Mapping ServicesPeptide Synthesis ServicesCustom Conjugation ServicePeptide Analysis ServicesPeptide Nucleic Acids SynthesiscGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers